Skip to content

To study the effect of compound unani formulation in the management of Stress Urinary Incontinence

Evaluation of Safuf-i-Masikul bawl in the management of Salas al-Bawl (Stress Urinary Incontinence): A Randomized,Parallel group, An Open label, Standard control study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082559
Enrollment
70
Registered
2025-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N393- Stress incontinence (female) (male)

Interventions

Intervention1: Safuf (powder): Its a classical unani formulation (Safuf-i-Masikul bawl) taken from Al-Qarabadeen. The formulation comprises of Balut (Quercus incana Roxb.), Kundur (Boswellia serrata

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Females in the age group of 20 to 70 years with symptoms of stress urinary incontinence. 2.Stress urinary incontinence more than or equal to 1 episode/week within the past 6 months or more. 3.Patients who are willing to participate in the clinical study voluntarily and are able to follow up.

Exclusion criteria

Exclusion criteria: 1.Patients with known history of systemic disease like uncontrolled diabetes mellitus, hypertension, hepatic dysfunction and impaired renal function. 2.Patients with continuous leakage of urine and enuresis. 3.Patients with urinary tract infection confirmed by microscopic examination of urine. 4.Patients having history of surgery for stress urinary incontinence within 6 months. 5.Known cases of pelvic pathology like fistula , fibroid and malignancy. 6.Known cases of third- degree and fourth- degree uterine prolapse. 7.Pregnant and lactating mothers. 8.Patients who refuse to give the written consent for the study and unwillingness to come for regular follow up.

Design outcomes

Primary

MeasureTime frame
1.Change from baseline to 41st day in the Cough Stress Test 2.Change from baseline to 41st day in 1-hour Pad testTimepoint: 40 days

Secondary

MeasureTime frame
1.International Consultation on Incontinence Questionnaire- urinary incontinence short form (ICIQ-UI SF) 2.Incontinence Impact Questionnaire, Short Form (IIQ-7)Timepoint: 0 day, 1oth day, 20th day,3oth day and 40th day.

Countries

India

Contacts

Public ContactSyed Farhanda Farooq

Regional Research Institute of Unani Medicine (RRIUM), Srinagar

hussainzaffar6@gmail.com7006021996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026